Unintentional medication discrepancies and postoperative adverse drug events in patients with cancer: A prospective cohort study
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70384 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Atefeh Mehrabifar und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Midwifery, Centre for Quality and Patient Safety Research, Institute for Health Transformation, Deakin University, Geelong, Vic…. Hauptthemen laut MEDLINE: Neoplasms, Medication Errors, Drug-Related Side Effects and Adverse Reactions, Postoperative Complications. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Aim
To understand regular medication management processes in the postoperative period for patients having major cancer surgery, and to evaluate whether medication discrepancies were associated with postoperative adverse drug events (ADEs).
Method
A prospective cohort of 500 adult patients, undergoing planned major cancer surgery at a Melbourne specialist cancer hospital, was followed from surgery to day 30 postoperatively. Regular medication discrepancies were assessed across transitions of care up to five days postoperatively and at discharge. Adverse drug events were monitored up to 30 days after surgery. Multivariable logistic regression was used to identify predictors of medication discrepancies and ADEs.
Results
Among 7254 medication orders for 500 patients, 12.5% ( n = 905) of orders resulted in unintentional medication discrepancies. Polypharmacy (OR = 1.32; 95%CI: 1.21–1.44; p < 0.001) and length of stay (OR = 1.07; 95%CI: 1.03–1.12; p = 0.001) were significant predictors of unintentional medication discrepancies. ADEs occurred in 16.4% of patients ( n = 82). In multivariable analysis, the odds of experiencing an ADE were significantly higher among patients who had unintentional discrepancies ( vs . those with intentional discrepancies; OR = 3.06; 95%CI: 1.66–5.64; p < 0.001), older age (OR = 1.05; 95%CI: 1.02–1.08; p < 0.001), polypharmacy (OR = 1.20; 95%CI: 1.08–1.33; p < 0.001), higher acuity care admission (OR = 2.46; 95%CI: 1.33–4.54; p = 0.004) and prolonged hospital length of stay (OR = 1.07; 95%CI: 1.02–1.12; p = 0.002). Cardiovascular and alimentary tract medications were most commonly implicated in both discrepancies and ADEs.
Conclusion
Unintentional medication discrepancies are associated with postoperative ADEs in patients having cancer surgery. Targeted strategies—especially for older patients, those with polypharmacy, and extended hospital stays—are essential to enhance medication safety across perioperative transitions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing and Midwifery, Centre for Quality and Patient Safety Research, Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia.
- Monash Nursing and Midwifery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
- School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
- Department of Anaesthetics, Perioperative Medicine, and Pain Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
- Research Department of Targeted Intervention, University College London, London, UK.
ORCID-Profile: Atefeh Mehrabifar, Elizabeth Manias, Thomas Poulton, Bernhard Riedel, Janelle Penno, Patricia Nicholson
Zitieren
APA
Mehrabifar, A., Manias, E., Poulton, T., Riedel, B., Penno, J., & Nicholson, P. (2026). Unintentional medication discrepancies and postoperative adverse drug events in patients with cancer: A prospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70384
Vancouver
Mehrabifar A, Manias E, Poulton T, Riedel B, Penno J, Nicholson P. Unintentional medication discrepancies and postoperative adverse drug events in patients with cancer: A prospective cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70384
BibTeX
@article{Mehrabifar2026,
author = {Mehrabifar, Atefeh and Manias, Elizabeth and Poulton, Thomas and Riedel, Bernhard and Penno, Janelle and Nicholson, Patricia},
title = {Unintentional medication discrepancies and postoperative adverse drug events in patients with cancer: A prospective cohort study},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70384}
}
EUVIMED